Janus Henderson Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.9M | Buy |
8,908,506
+1,504,120
| +20% | +$11.7M | 0.04% | 310 |
|
|
2025
Q4 | $57.8M | Buy |
7,404,386
+7,310,745
| +7,807% | +$52.9M | 0.03% | 387 |
|
|
2025
Q3 | $710K | Buy |
93,641
+14,309
| +18% | +$119K | ﹤0.01% | 1841 |
|
|
2025
Q2 | $710K | Hold |
79,332
| – | – | ﹤0.01% | 1780 |
|
|
2025
Q1 | $624K | Hold |
79,332
| – | – | ﹤0.01% | 1845 |
|
|
2024
Q4 | $596K | Hold |
79,332
| – | – | ﹤0.01% | 1952 |
|
|
2024
Q3 | $603K | Hold |
79,332
| – | – | ﹤0.01% | 1943 |
|
|
2024
Q2 | $491K | Sell |
79,332
-1,053
| -1% | -$5.81K | ﹤0.01% | 1997 |
|
|
2024
Q1 | $407K | Buy |
80,385
+98
| +0.1% | +$551 | ﹤0.01% | 2104 |
|
|
2023
Q4 | $481K | Sell |
80,287
-156
| -0.2% | -$904 | ﹤0.01% | 2006 |
|
|
2023
Q3 | $569K | Buy |
80,443
+7
| +0% | +$50 | ﹤0.01% | 1856 |
|
|
2023
Q2 | $566K | Sell |
80,436
-86
| -0.1% | -$690 | ﹤0.01% | 1911 |
|
|
2023
Q1 | $672K | Sell |
80,522
-1,969,504
| -96% | -$19M | ﹤0.01% | 1856 |
|
|
2022
Q4 | $23.5M | Buy |
2,050,026
+1,978,070
| +2,749% | +$24.7M | 0.02% | 538 |
|
|
2022
Q3 | $906K | Buy |
71,956
+36,055
| +100% | +$464K | ﹤0.01% | 1692 |
|
|
2022
Q2 | $380K | Sell |
35,901
-30
| -0.1% | -$309 | ﹤0.01% | 1925 |
|
|
2022
Q1 | $584K | Buy |
35,931
+9
| +0% | +$144 | ﹤0.01% | 1804 |
|
|
2021
Q4 | $498K | Buy |
35,922
+18,068
| +101% | +$239K | ﹤0.01% | 1898 |
|
|
2021
Q3 | $257K | Buy |
+17,854
| New | +$282K | ﹤0.01% | 1964 |
|
|
2020
Q2 | – | Sell |
-4,877,731
| Closed | -$9.76M | – | 1311 |
|
|
2020
Q1 | $9.76M | Sell |
4,877,731
-4,530,750
| -48% | -$12.5M | 0.01% | 820 |
|
|
2019
Q4 | $32.5M | Sell |
9,408,481
-112,083
| -1% | -$282K | 0.02% | 715 |
|
|
2019
Q3 | $27.3M | Sell |
9,520,564
-75,780
| -0.8% | -$236K | 0.01% | 755 |
|
|
2019
Q2 | $36.4M | Sell |
9,596,344
-2,661,098
| -22% | -$16M | 0.02% | 662 |
|
|
2019
Q1 | $99.8M | Sell |
12,257,442
-45,113
| -0.4% | -$386K | 0.06% | 381 |
|
|
2018
Q4 | $99.3M | Buy |
12,302,555
+52,394
| +0.4% | +$407K | 0.06% | 347 |
|
|
2018
Q3 | $93.5M | Buy |
12,250,161
+1,153,978
| +10% | +$7.75M | 0.05% | 417 |
|
|
2018
Q2 | $63.6M | Buy |
11,096,183
+3,441,498
| +45% | +$18.9M | 0.04% | 488 |
|
|
2018
Q1 | $36.5M | Buy |
7,654,685
+915,419
| +14% | +$4.7M | 0.02% | 632 |
|
|
2017
Q4 | $33.1M | Buy |
6,739,266
+2,204,539
| +49% | +$10.7M | 0.02% | 641 |
|
|
2017
Q3 | $23.8M | Buy |
+4,534,727
| New | +$23.2M | 0.02% | 701 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC
